These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 16410224)
1. Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling. Schmidt A; Wenzel D; Thorey I; Werner S; Fleischmann BK; Bloch W Endothelium; 2005; 12(5-6):251-7. PubMed ID: 16410224 [TBL] [Abstract][Full Text] [Related]
2. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin. Urbich C; Reissner A; Chavakis E; Dernbach E; Haendeler J; Fleming I; Zeiher AM; Kaszkin M; Dimmeler S FASEB J; 2002 May; 16(7):706-8. PubMed ID: 11978735 [TBL] [Abstract][Full Text] [Related]
3. Endostatin influences endothelial morphology via the activated ERK1/2-kinase endothelial morphology and signal transduction. Schmidt A; Wenzel D; Thorey I; Sasaki T; Hescheler J; Timpl R; Addicks K; Werner S; Fleischmann BK; Bloch W Microvasc Res; 2006 May; 71(3):152-62. PubMed ID: 16650878 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization. Zhang M; Yang Y; Yan M; Zhang J Exp Eye Res; 2006 Jan; 82(1):74-80. PubMed ID: 16198337 [TBL] [Abstract][Full Text] [Related]
5. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function. Campbell M; Collery R; McEvoy A; Gardiner TA; Stitt AW; Brankin B Curr Eye Res; 2006 Dec; 31(12):1033-45. PubMed ID: 17169842 [TBL] [Abstract][Full Text] [Related]